Free Trial
NASDAQ:SBTX

Silverback Therapeutics (SBTX) Stock Price, News & Analysis

Silverback Therapeutics logo
$12.86 -0.58 (-4.32%)
As of 08/28/2025

About Silverback Therapeutics Stock (NASDAQ:SBTX)

Key Stats

Today's Range
$12.84
$13.46
50-Day Range
$13.44
$18.35
52-Week Range
$2.80
$8.97
Volume
2.55 million shs
Average Volume
337,931 shs
Market Capitalization
$463.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SBTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silverback Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SBTX Stock News Headlines

ARS Pharmaceuticals Inc (SPRY)
SPRY ARS Pharmaceuticals, Inc.
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.tc pixel
See More Headlines

SBTX Stock Analysis - Frequently Asked Questions

Silverback Therapeutics' stock was trading at $10.55 at the beginning of the year. Since then, SBTX shares have increased by 21.9% and is now trading at $12.86.

Silverback Therapeutics, Inc. (NASDAQ:SBTX) released its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.65) EPS for the quarter, hitting analysts' consensus estimates of ($0.65).

Silverback Therapeutics (SBTX) raised $126 million in an initial public offering on Friday, December 4th 2020. The company issued 7,000,000 shares at a price of $17.00-$19.00 per share. Goldman Sachs, SVB Leerink and Stifel served as the underwriters for the IPO and H.C. Wainwright was co-manager.

Shares of SBTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Silverback Therapeutics investors own include Athenex (ATNX), AbbVie (ABBV), Applied Materials (AMAT), JPMorgan Chase & Co. (JPM), Luminar Technologies (LAZR), Lineage Cell Therapeutics (LCTX) and Aviat Networks (AVNW).

Company Calendar

Last Earnings
11/10/2021
Today
8/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SBTX
CIK
1671858
Fax
N/A
Employees
83
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.42)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$89.48 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-29.62%
Return on Assets
-28.20%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
67.87
Quick Ratio
67.87

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.41 per share
Price / Book
1.81

Miscellaneous

Outstanding Shares
36,058,000
Free Float
23,654,000
Market Cap
$484.62 million
Optionable
Not Optionable
Beta
0.60

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:SBTX) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners